OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
3.300
+0.050 (1.54%)
May 28, 2025, 4:00 PM - Market closed
OncoCyte Market Cap
OncoCyte has a market cap or net worth of $94.38 million as of May 28, 2025. Its market cap has increased by 298.22% in one year.
Market Cap
94.38M
Enterprise Value
65.40M
1-Year Change
298.22%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since January 4, 2016, OncoCyte's market cap has decreased from $228.70M to $94.38M, a decrease of -58.73%. That is a compound annual growth rate of -8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 92.90M | 131.67% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.06B |
| Johnson & Johnson | 368.73B |
| AbbVie | 328.06B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 267.61B |
| Abbott Laboratories | 231.29B |
| Novartis AG | 221.98B |
| AstraZeneca | 219.74B |